Physical Activity and Cardiometabolic Health in Women With or Without Polycystic Ovary Syndrome (SCOPAP)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

The primary objective of this study is to investigate the effects of a multidisciplinary intervention, including a targeted adapted physical activity program, on lipid oxidation during a walking exercise in women with overweight or obesity, with or without polycystic ovary syndrome. Specifically, the study aims to compare changes in lipid oxidation before and after the intervention between women with polycystic ovary syndrome and those without polycystic ovary syndrome.

The secondary objectives are to assess the impact of polycystic ovary syndrome on several physiological and metabolic parameters in women with overweight or obesity. These include: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during a walking exercise; (iv) body composition, glycemic and lipid profiles, and circulating levels of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness.

In addition, the effect of the multidisciplinary intervention, including the adapted physical activity program, will be evaluated on these same outcomes: (i) resting energy metabolism; (ii) resting blood pressure and heart rate; (iii) energy expenditure, energy cost, and heart rate during walking exercise; (iv) body composition, glycemic and lipid profiles, and concentrations of sex hormones and adipokines; (v) movement behaviors; and (vi) physical fitness, in women with overweight or obesity, with or without polycystic ovary syndrome.

Eligibility criteria

Qualifiers

Women aged 18 to 40 years (inclusive boundaries)

Women with a body mass index (BMI) between 25 and 40 kg/m²

Women performing no more than 150 minutes of moderate-to-vigorous physical activity per week

Women able to provide informed consent to participate

Disqualifiers

Pregnancy or breastfeeding, as declared by the participant

Postmenopausal women

Women currently receiving pharmacological treatment for obesity or who have received such treatment within the past two years

Women under legal protection measures (guardianship, curatorship, or judicial protection)

Trial design

Treatments tested in this trial

  • Physical activity

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital, Clermont-Ferrand

Lead sponsor

SMR Nutrition Obésité UGECAM

Collaborator

Laboratoire AME2P

Collaborator